Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-27
DOI
10.1007/s10096-023-04675-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)
- (2022) Juan José Castón et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
- (2022) Christopher JL Murray et al. LANCET
- OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline
- (2022) Sara E. Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae
- (2022) O. Lima et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance
- (2021) Mario Rivera-Izquierdo et al. Antibiotics-Basel
- Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates
- (2021) Mariana Castanheira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
- (2021) Mical Paul et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis
- (2020) Wei-min Zhu et al. Antimicrobial Resistance and Infection Control
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- A Cohort Study of the Impact of Carbapenem-Resistant Enterobacteriaceae Infections on Mortality of Patients Presenting with Sepsis
- (2019) Sabrina Sabino et al. mSphere
- Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other among Patients with Serious Infections due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
- (2019) Thomas Lodise et al. Open Forum Infectious Diseases
- The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region
- (2019) Şirin Menekşe et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment
- (2019) Jorge Rodriguez-Gómez et al. JOURNAL OF INFECTION
- Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
- (2019) Patrice Nordmann et al. CLINICAL INFECTIOUS DISEASES
- The Global Ascendency of OXA-48-Type Carbapenemases
- (2019) Johann D. D. Pitout et al. CLINICAL MICROBIOLOGY REVIEWS
- Assessment of Mortality Stratified by Meropenem MIC in Patients with Enterobacteriaceae Bacteremia: A Patient-level Analysis of Published Data
- (2019) J. Nicholas O'Donnell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pathogenicity of Clinical OXA-48 Isolates and Impact of the OXA-48 IncL Plasmid on Virulence and Bacterial Fitness
- (2019) Axel Hamprecht et al. Frontiers in Microbiology
- Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection
- (2018) Fusun Can et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Whole genome sequencing, molecular typing and in vivo virulence of OXA-48-producing Escherichia coli isolates including ST131 H30-Rx, H22 and H41 subclones
- (2017) María de Toro et al. Scientific Reports
- Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program
- (2016) Elizabeth Temkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
- (2016) Boudewijn L. M. de Jonge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-ResistantEnterobacteriaceaeBacteremia
- (2016) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
- (2016) Zaira R. Palacios-Baena et al. JOURNAL OF INFECTION
- Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals HighIn VitroSusceptibility to Colistin and Meropenem
- (2015) Jesús Oteo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections
- (2015) Warren Lowman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Mortality due toblaKPCKlebsiella pneumoniaebacteraemia
- (2015) Yedidah Fraenkel-Wandel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit
- (2015) Konstantinos Z. Vardakas et al. JOURNAL OF INFECTION
- Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
- (2014) Ilker Inanç Balkan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Clinical Outcomes of Enterobacteriaceae Infections Stratified by Carbapenem MICs
- (2014) Twisha S. Patel et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli
- (2013) R. Beyrouthy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
- (2012) C. Navarro-San Francisco et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
- (2012) Wouter C. Rottier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
- (2012) J. R. Pano-Pardo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain
- (2012) J. Oteo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug?
- (2012) Konstantinos Z. Vardakas et al. JOURNAL OF INFECTION
- Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
- (2011) D. Ben-David et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prospective Observational Study of the Impact of VIM-1 Metallo- -Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
- (2009) G. L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
- (2008) Teresa C. Horan et al. AMERICAN JOURNAL OF INFECTION CONTROL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started